Alpha Family Trust Has $927,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Alpha Family Trust lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,820 shares of the healthcare conglomerate’s stock after selling 150 shares during the quarter. Alpha Family Trust’s holdings in UnitedHealth Group were worth $927,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after acquiring an additional 544,740 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in UnitedHealth Group by 0.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after purchasing an additional 94,641 shares during the period. Capital Research Global Investors boosted its stake in UnitedHealth Group by 2.2% in the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after purchasing an additional 324,733 shares during the period. Capital International Investors boosted its stake in UnitedHealth Group by 4.8% in the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after purchasing an additional 542,424 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after purchasing an additional 35,533 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.9 %

Shares of NYSE UNH opened at $589.16 on Tuesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $607.94. The company’s 50 day moving average price is $571.08 and its 200-day moving average price is $518.38. The company has a market capitalization of $542.25 billion, a P/E ratio of 36.01, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the prior year, the company posted $6.14 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.43%. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Ratings Changes

Several analysts recently issued reports on UNH shares. Morgan Stanley boosted their price target on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. HSBC lifted their price objective on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Wells Fargo & Company lifted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Monday. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $614.17.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.